ArticleFrontiers in immunology2025

Neoadjuvant immunotherapy plus chemotherapy for resectable non-small cell lung cancer with driver mutations: a retrospective analysis.

Junhao Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.